Insider transaction feed
Latest SEC Form 4 insider trades with explainable signal scoring.
13,064 transactions Export CSV
Buy volume
$1.69B
7315 buy transactions
Sell volume
$16.43B
5749 sell transactions
Net flow
-$14.74B
Net selling
Total flow
$18.12B
13064 priced transactions
Net insider flow· last 30 days
Buys Sellsnet -$15.00B
Convergence— where independent disclosures line up
View all signals →
| Transaction | Flags | ||||||||
|---|---|---|---|---|---|---|---|---|---|
14d ago Jun 25, 2026 | PLUG POWER INC | Conway Gerard L JR Gen. Coun, Corp Sec., Exec. VP | Buy · A | 362,694 | $0.00 | $0 | Neutral+2 | Deriv | |
14d ago Jun 25, 2026 | PLUG POWER INC | Conway Gerard L JR Gen. Coun, Corp Sec., Exec. VP | Buy · A | 357,143 | $0.00 | $0 | Neutral+2 | Deriv | |
14d ago Jun 25, 2026 | PLUG POWER INC | Fullerton Dean Chief Operating Officer | Buy · A | 414,508 | $0.00 | $0 | Neutral+5 | Deriv | |
14d ago Jun 25, 2026 | PLUG POWER INC | Fullerton Dean Chief Operating Officer | Buy · A | 408,163 | $0.00 | $0 | Neutral+5 | Deriv | |
14d ago Jun 25, 2026 | PLUG POWER INC | Crespo Jose Luis See Remarks | Buy · A | 777,202 | $0.00 | $0 | Neutral+2 | Deriv | |
14d ago Jun 25, 2026 | PLUG POWER INC | Crespo Jose Luis See Remarks | Buy · A | 765,306 | $0.00 | $0 | Neutral+2 | Deriv | |
14d ago Jun 26, 2026 | AGILENT TECHNOLOGIES, INC. | KIRKWOOD JONAH PREVOST Senior Vice President | Sell · F | 30 | $136.01 | $4.1K | Neutral+5 | ||
14d ago Jun 25, 2026 | Aon plc | SMITH SARAH G Director | Sell · F | 186 | $315.95 | $58.8K | Neutral+2 | ||
14d ago Jun 25, 2026 | Aon plc | SMITH SARAH G Director | Buy · A | 776 | — | — | Neutral+2 | ||
14d ago Jun 26, 2026 | GAIA, INC | Preston Ned CFO | Sell · F | 21,417 | $2.08 | $44.5K | Neutral+5 | ||
14d ago Jun 26, 2026 | GAIA, INC | Preston Ned CFO | Buy · A | 76,220 | $2.08 | $158.5K | Neutral+5 | ||
14d ago Jun 26, 2026 | vTv Therapeutics Inc. | BAKER BROS. ADVISORS LP Director | Buy · A | 6,000 | $0.00 | $0 | Neutral+2 | Deriv | |
14d ago Jun 26, 2026 | vTv Therapeutics Inc. | BAKER BROS. ADVISORS LP Director | Buy · A | 6,000 | $0.00 | $0 | Neutral+2 | Deriv | |
14d ago Jun 25, 2026 | Hongchang International Co., Ltd | Lin Zhenzhu Director · 10% Owner | Sell · S | 9,998 | $0.11 | $1.1K | Mild sell-16 | Late | |
14d ago Jun 24, 2026 | Hongchang International Co., Ltd | Lin Zhenzhu Director · 10% Owner | Sell · S | 5,000 | $0.11 | $560 | Mild sell-16 | Late | |
14d ago Jun 23, 2026 | Hongchang International Co., Ltd | Lin Zhenzhu Director · 10% Owner | Sell · S | 1,450 | $0.12 | $174 | Mild sell-16 | Late | |
14d ago Jun 26, 2026 | WORTHINGTON ENTERPRISES, INC. | CHAN KEVIN J Controller | Buy · A | 4 | $56.35 | $245 | Neutral+2 | Deriv | |
14d ago Jun 25, 2026 | WORTHINGTON ENTERPRISES, INC. | CHAN KEVIN J Controller | Buy · A | 1,030 | $0.00 | $0 | Neutral+2 | ||
14d ago Jun 26, 2026 | WORTHINGTON ENTERPRISES, INC. | HAYEK JOSEPH B President & CEO · Director | Buy · A | 5 | $56.35 | $277 | Neutral+6 | Deriv | |
14d ago Jun 26, 2026 | WORTHINGTON ENTERPRISES, INC. | HAYEK JOSEPH B President & CEO · Director | Sell · F | 1,472 | $56.35 | $82.9K | Neutral+6 | ||
14d ago Jun 25, 2026 | WORTHINGTON ENTERPRISES, INC. | HAYEK JOSEPH B President & CEO · Director | Buy · A | 4,610 | $0.00 | $0 | Neutral+6 | ||
14d ago Jun 25, 2026 | WORTHINGTON ENTERPRISES, INC. | HAYEK JOSEPH B President & CEO · Director | Buy · A | 9,230 | $0.00 | $0 | Neutral+6 | ||
14d ago Jun 25, 2026 | WORTHINGTON ENTERPRISES, INC. | HAYEK JOSEPH B President & CEO · Director | Buy · A | 19,900 | $0.00 | $0 | Neutral+6 | ||
14d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Buy · M | 9,500 | $0.00 | $0 | Neutral+1 | 10b5-1Deriv | |
14d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 40 | $553.49 | $22.1K | Neutral+1 | 10b5-1 | |
14d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 280 | $552.36 | $154.7K | Neutral+1 | 10b5-1 | |
14d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 400 | $550.79 | $220.3K | Neutral+1 | 10b5-1 | |
14d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 520 | $549.69 | $285.8K | Neutral+1 | 10b5-1 | |
14d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 872 | $548.90 | $478.6K | Neutral+1 | 10b5-1 | |
14d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 452 | $548.13 | $247.8K | Neutral+1 | 10b5-1 | |
14d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 156 | $547.00 | $85.3K | Neutral+1 | 10b5-1 | |
14d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 560 | $545.52 | $305.5K | Neutral+1 | 10b5-1 | |
14d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 439 | $544.18 | $238.9K | Neutral+1 | 10b5-1 | |
14d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 1,012 | $543.32 | $549.8K | Neutral+1 | 10b5-1 | |
14d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 983 | $542.14 | $532.9K | Neutral+1 | 10b5-1 | |
14d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 2,128 | $541.24 | $1.15M | Neutral+1 | 10b5-1 | |
14d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 1,018 | $539.89 | $549.6K | Neutral+1 | 10b5-1 | |
14d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 640 | $538.34 | $344.5K | Neutral+1 | 10b5-1 | |
14d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Buy · M | 9,500 | $135.42 | $1.29M | Neutral+1 | 10b5-1 | |
14d ago Jun 25, 2026 | Navan, Inc. | KOUREY MICHAEL R Director | Buy · A | 9,959 | $0.00 | $0 | Neutral+2 | ||
14d ago Jun 26, 2026 | ACADIA PHARMACEUTICALS INC | Kihara James PRINCIPAL ACCOUNTING OFFICER | Sell · S | 11,421 | $26.08 | $297.9K | Neutral-5 | 10b5-1 | |
14d ago Jun 25, 2026 | QuidelOrtho Corp | WIDDER KENNETH J Director | Buy · A | 1,997 | $0.00 | $0 | Neutral+2 | Deriv | |
14d ago Jun 25, 2026 | QuidelOrtho Corp | WIDDER KENNETH J Director | Buy · A | 6,656 | $0.00 | $0 | Neutral+2 | Deriv | |
14d ago Jun 25, 2026 | QuidelOrtho Corp | WIDDER KENNETH J Director | Buy · A | 15,532 | $0.00 | $0 | Neutral+2 | Deriv | |
14d ago Jun 24, 2026 | CYTOKINETICS INC | Lee Sung EVP, Chief Financial Officer | Buy · M | 1,113 | $0.00 | $0 | Mild sell-23 | LateDeriv | |
14d ago Jun 24, 2026 | CYTOKINETICS INC | Lee Sung EVP, Chief Financial Officer | Buy · M | 822 | $0.00 | $0 | Mild sell-23 | LateDeriv | |
14d ago Jun 24, 2026 | CYTOKINETICS INC | Lee Sung EVP, Chief Financial Officer | Buy · M | 188 | $0.00 | $0 | Mild sell-23 | LateDeriv | |
14d ago Jun 24, 2026 | CYTOKINETICS INC | Lee Sung EVP, Chief Financial Officer | Buy · M | 1,113 | $0.00 | $0 | Mild sell-23 | LateDeriv | |
14d ago Jun 24, 2026 | CYTOKINETICS INC | Lee Sung EVP, Chief Financial Officer | Buy · M | 2,817 | $0.00 | $0 | Mild sell-23 | LateDeriv | |
14d ago Jun 24, 2026 | CYTOKINETICS INC | Lee Sung EVP, Chief Financial Officer | Buy · M | 9,307 | $0.00 | $0 | Mild sell-23 | LateDeriv |
